SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-009317
Filing Date
2014-02-14
Accepted
2014-02-14 12:29:43
Documents
1
Period of Report
2014-02-14
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K CURRENT REPORT v368831_8k.htm 8-K 12979
  Complete submission text file 0001144204-14-009317.txt   14075
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 14613439
SIC: 2836 Biological Products, (No Diagnostic Substances)